{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:51:30Z","timestamp":1781635890959,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005760","name":"University of Gothenburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Obesity and type 2 diabetes (T2DM) are considered risk factors for complications following total hip arthroplasty (THA). How these risk factors separately or in combination influence the risk of reoperation due to periprosthetic joint infection (PJI) or all-cause reoperation is not fully known. We sought to investigate the 2-year risk of reoperation following THA due to osteoarthritis (OA) among people with and without the metabolic risk factors, T2DM and obesity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We linked all patients with THA registered during 2008\u20132019 in the Swedish Hip Arthroplasty Register (SHAR) to the National Diabetes Register. The risk of reoperation was analysed by applying Kaplan\u2013Meier (KM) and multivariable Cox regression analyses. Subgroup analyses were performed to explore the effect modification by obesity. After THA exclusions (such as bilateral THA observations and other diagnoses than OA) there were 14,512 individuals identified with T2DM and 116,579 without. The primary outcome was reoperation due to PJI within two years after THA. The secondary outcome was reoperation due to any cause within two years after THA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>2-year 1\u2013KM reoperation estimate for reoperation due to PJI was 1.69% with 95% confidence interval (95%CI) 1.47\u20131.90 among individuals with T2DM and 1.02% (95%CI 0.96\u20131.08) among those without T2DM. The 1\u2013KM reoperation estimate for reoperation due to any cause was 2.67% (95%CI 2.40\u20132.94) for the T2DM group, and 1.99% (95%CI 1.91\u20132.07) for non-T2DM. However, adjusted for Body Mass Index (BMI), T2DM was not a statistically significant risk factor (infection-related reoperation: adjusted hazard ratio (aHR) 1.1 with 95% confidence interval (95%CI) 0.9\u20131.3; all-cause reoperation: aHR 1.0, 95%CI 0.9\u20131.2). In the BMI subgroup analyses, T2DM associated increased risk of reoperation due to PJI was limited to normal\/underweight individuals (aHR 1.6 95%CI 1.1\u20132.4). In the subgroups with overweight or obesity, T2DM was neither associated with increased risk of all-cause reoperation nor reoperation due to PJI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Overall, T2DM is not an independent risk factor for reoperation when adjusted for BMI. However, T2DM constitutes a minor risk factor in individuals of normal\/underweight. Risk of reoperation was more strongly associated with BMI rather than T2DM, suggesting that the additional risk observed in obese patients is likely influenced by multiple interrelated factors beyond T2DM alone.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12891-026-09568-5","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T06:54:45Z","timestamp":1770101685000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Type 2 diabetes is not associated with excess risk of periprosthetic joint infection in obese patients undergoing total hip arthroplasty"],"prefix":"10.1186","volume":"27","author":[{"given":"Aurora","family":"Tasa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Vinblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonatan","family":"N\u00e5tman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonatan","family":"Tillander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Nyberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Englund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Rolfson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"issue":"3","key":"9568_CR1","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3109\/17453674.2014.913224","volume":"85","author":"S Nemes","year":"2014","unstructured":"Nemes S, Gordon M, Rogmark C, Rolfson O. Projections of total hip replacement in Sweden from 2013 to 2030. Acta Orthop. 2014;85(3):238\u201343. https:\/\/doi.org\/10.3109\/17453674.2014.913224. Epub 2014 Apr 23. PMID: 24758323; PMCID: PMC4062789.","journal-title":"Acta Orthop"},{"key":"9568_CR2","unstructured":"K\u00e4rrholm J, Rogmark C, Naucl\u00e9r E, et al. The Swedish Hip Arthroplasty Register Annual Report 2019. Available at: https:\/\/registercentrum.blob.core.windows.net\/shpr\/r\/VGR_Annual-report_SHAR_2019_EN_Digital-pages_FINAL-ryxaMBUWZ_.pdf. Accessed 11 Feb 2022."},{"issue":"11","key":"9568_CR3","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/j.joca.2014.07.015","volume":"22","author":"A Turkiewicz","year":"2014","unstructured":"Turkiewicz A, Petersson IF, Bjork J, et al. Current and future impact of osteoarthritis on health care: a population-based study with projections to year 2032. Osteoarthritis Cartilage. 2014;22(11):1826\u201332.","journal-title":"Osteoarthritis Cartilage"},{"issue":"12","key":"9568_CR4","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nrrheum.2012.135","volume":"8","author":"Q Zhuo","year":"2012","unstructured":"Zhuo Q, Yang W, Chen J, Wang Y. Metabolic syndrome Meets osteoarthritis. Nat Rev Rheumatol. 2012;8(12):729\u201337. https:\/\/doi.org\/10.1038\/nrrheum.2012.135. Epub 2012 Aug 21. PMID: 22907293.","journal-title":"Nat Rev Rheumatol"},{"key":"9568_CR5","unstructured":"Gudbj\u00f6rnsdottir S, Eeg-Olofsson K, Miftaraj M, et al. The Swedish National Diabetes Register Annual Report 2020. Available at: https:\/\/registercentrum.blob.core.windows.net\/ndr\/r\/Arsrapport_NDR_2019-H1ek0RZ9Tj.pdf. Accessed 30 Sept 2024."},{"issue":"11","key":"9568_CR6","doi-asserted-by":"publisher","first-page":"e0143084","DOI":"10.1371\/journal.pone.0143084","volume":"10","author":"T Andersson","year":"2015","unstructured":"Andersson T, Ahlbom A, Carlsson S. Diabetes prevalence in Sweden at present and projections for year 2050. PLoS ONE. 2015;10(11):e0143084.","journal-title":"PLoS ONE"},{"issue":"7640","key":"9568_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature21363","volume":"542","author":"GS Hotamisligil","year":"2017","unstructured":"Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542(7640):177\u201385.","journal-title":"Nature"},{"issue":"4","key":"9568_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nrrheum.2012.224","volume":"9","author":"AE Wluka","year":"2013","unstructured":"Wluka AE, Lombard CB, Cicuttini FM. Tackling obesity in knee osteoarthritis. Nat Rev Rheumatol. 2013;9(4):225\u201335.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"9568_CR9","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1080\/17453674.2019.1594015","volume":"90","author":"AS Sayed-Noor","year":"2019","unstructured":"Sayed-Noor AS, Mukka S, Mohaddes M, et al. Body mass index is associated with risk of reoperation and revision after primary total hip arthroplasty: a study of the Swedish hip arthroplasty register including 83,146 patients. Acta Orthop. 2019;90(3):220\u20135.","journal-title":"Acta Orthop"},{"issue":"3","key":"9568_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2106\/JBJS.O.00430","volume":"98","author":"ER Wagner","year":"2016","unstructured":"Wagner ER, Kamath AF, Fruth KM, et al. Effect of body mass index on complications and reoperations after total hip arthroplasty. J Bone Joint Surg Am. 2016;98(3):169\u201379.","journal-title":"J Bone Joint Surg Am"},{"issue":"2","key":"9568_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5435\/JAAOS-D-20-00028","volume":"29","author":"KJ Kebaish","year":"2021","unstructured":"Kebaish KJ, Puvanesarajah V, Rao S, et al. Diabetes status affects odds of body mass Index-dependent adverse outcomes after total hip arthroplasty. J Am Acad Orthop Surg. 2021;29(2):71\u20137.","journal-title":"J Am Acad Orthop Surg"},{"key":"9568_CR12","doi-asserted-by":"publisher","unstructured":"Webb ML, Justen MA, Kerbel YE, et al. Patients with insulin-dependent diabetes are at greater risk for perioperative adverse outcomes following total hip arthroplasty. HIP Int. 2021;32(6):730-6. https:\/\/doi.org\/10.1177\/1120700020988834.","DOI":"10.1177\/1120700020988834"},{"issue":"5","key":"9568_CR13","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.arth.2013.02.011","volume":"28","author":"Workgroup of the American Association of Hip and Knee Surgeons Evidence Based C","year":"2013","unstructured":"Workgroup of the American Association of Hip and Knee Surgeons Evidence Based C. Obesity and total joint arthroplasty: a literature-based review. J Arthroplasty. 2013;28(5):714\u201321.","journal-title":"J Arthroplasty"},{"issue":"6","key":"9568_CR14","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1097\/CORR.0000000000001210","volume":"478","author":"E B\u00fclow","year":"2020","unstructured":"B\u00fclow E, Nemes S, Rolfson O. Are the first or the second hips of staged bilateral THAs more similar to unilateral procedures? A study from the Swedish hip arthroplasty register. Clin Orthop Relat Res. 2020;478(6):1262\u201370.","journal-title":"Clin Orthop Relat Res"},{"issue":"4","key":"9568_CR15","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1080\/17453674.2019.1605785","volume":"90","author":"RJ Ferguson","year":"2019","unstructured":"Ferguson RJ, Silman AJ, Combescure C, et al. ASA class is associated with early revision and reoperation after total hip arthroplasty: an analysis of the Geneva and Swedish hip arthroplasty registries. Acta Orthop. 2019;90(4):324\u201330.","journal-title":"Acta Orthop"},{"issue":"6","key":"9568_CR16","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3109\/17453674.2012.742394","volume":"83","author":"V Lindgren","year":"2012","unstructured":"Lindgren V, Garellick G, K\u00e4rrholm J, et al. The type of surgical approach influences the risk of revision in total hip arthroplasty: a study from the Swedish hip arthroplasty register of 90,662 total hip replacements with 3 different cemented prostheses. Acta Orthop. 2012;83(6):559\u201365.","journal-title":"Acta Orthop"},{"key":"9568_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/1471-2474-13-251","volume":"13","author":"JJ Prokopetz","year":"2012","unstructured":"Prokopetz JJ, Losina E, Bliss RL, et al. Risk factors for revision of primary total hip arthroplasty: a systematic review. BMC Musculoskelet Disord. 2012;13:251.","journal-title":"BMC Musculoskelet Disord"},{"issue":"5","key":"9568_CR18","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.jdiacomp.2016.02.016","volume":"30","author":"MF Williams","year":"2016","unstructured":"Williams MF, London DA, Husni EM, et al. Type 2 diabetes and osteoarthritis: a systematic review and meta-analysis. J Diabetes Complications. 2016;30(5):944\u201350. https:\/\/doi.org\/10.1016\/j.jdiacomp.2016.02.016. Epub 2016 Mar 2. PMID: 27114387.","journal-title":"J Diabetes Complications"},{"issue":"20","key":"9568_CR19","doi-asserted-by":"publisher","first-page":"e3739","DOI":"10.1097\/MD.0000000000003739","volume":"95","author":"JTH Nielen","year":"2016","unstructured":"Nielen JTH, Emans PJ, Dagnelie PC, et al. Severity of diabetes mellitus and total hip or knee replacement: A Population-Based Case-Control study. Med (Baltim). 2016;95(20):e3739.","journal-title":"Med (Baltim)"},{"issue":"1","key":"9568_CR20","doi-asserted-by":"publisher","first-page":"e000077","DOI":"10.1136\/rmdopen-2015-000077","volume":"1","author":"K Louati","year":"2015","unstructured":"Louati K, Vidal C, Berenbaum F, et al. Association between diabetes mellitus and osteoarthritis: systematic literature review and meta-analysis. RMD Open. 2015;1(1):e000077.","journal-title":"RMD Open"},{"issue":"6","key":"9568_CR21","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.jbspin.2018.12.005","volume":"86","author":"A Courties","year":"2019","unstructured":"Courties A, Berenbaum F, Sellam J. The phenotypic approach to osteoarthritis: A look at metabolic Syndrome-Associated osteoarthritis. Joint Bone Spine. 2019;86(6):725\u201330.","journal-title":"Joint Bone Spine"},{"issue":"11","key":"9568_CR22","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1016\/j.arth.2016.04.030","volume":"31","author":"KH Jahng","year":"2016","unstructured":"Jahng KH, Bas MA, Rodriguez JA, et al. Risk factors for wound complications after direct anterior approach hip arthroplasty. J Arthroplasty. 2016;31(11):2583\u20137.","journal-title":"J Arthroplasty"},{"issue":"9","key":"9568_CR23","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1302\/2058-5241.3.180011","volume":"3","author":"M Barrett","year":"2018","unstructured":"Barrett M, Prasad A, Boyce L, et al. Total hip arthroplasty outcomes in morbidly obese patients: A systematic review. EFORT Open Rev. 2018;3(9):507\u201312.","journal-title":"EFORT Open Rev"},{"issue":"9","key":"9568_CR24","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/j.arth.2016.02.023","volume":"31","author":"RJ Hanly","year":"2016","unstructured":"Hanly RJ, Marvi SK, Whitehouse SL, et al. Morbid obesity in total hip arthroplasty: redefining outcomes for operative Time, length of Stay, and readmission. J Arthroplasty. 2016;31(9):1949\u201353.","journal-title":"J Arthroplasty"},{"key":"9568_CR25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jclinane.2015.12.037","volume":"32","author":"N Shaparin","year":"2016","unstructured":"Shaparin N, Widyn J, Nair S, et al. Does the obesity paradox apply to early postoperative complications after hip surgery? A retrospective chart review. J Clin Anesth. 2016;32:84\u201391.","journal-title":"J Clin Anesth"},{"issue":"9","key":"9568_CR26","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1302\/0301-620X.93B9.26873","volume":"93","author":"AM Davis","year":"2011","unstructured":"Davis AM, Wood AM, Keenan AC, et al. Does body mass index affect clinical outcome post-operatively and at five years after primary unilateral total hip replacement performed for osteoarthritis? A multivariate analysis of prospective data. J Bone Joint Surg Br. 2011;93(9):1178\u201382.","journal-title":"J Bone Joint Surg Br"},{"key":"9568_CR27","unstructured":"K\u00e4rrholm J, Lindahl H, Malchau H, et al. The Swedish Hip Arthroplasty Register Annual Report 2016. Available from: https:\/\/registercentrum.blob.core.windows.net\/shpr\/r\/Annual-Report-2016-B1eWEH-mHM.pdf. Accessed 11 Feb 2022."},{"issue":"5","key":"9568_CR28","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.arth.2011.09.013","volume":"27","author":"R Iorio","year":"2012","unstructured":"Iorio R, Williams KM, Marcantonio AJ, et al. Diabetes mellitus, hemoglobin A1C, and the incidence of total joint arthroplasty infection. J Arthroplasty. 2012;27(5):726\u2013e91.","journal-title":"J Arthroplasty"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-026-09568-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-026-09568-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-026-09568-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:52:38Z","timestamp":1781632358000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12891-026-09568-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9568"],"URL":"https:\/\/doi.org\/10.1186\/s12891-026-09568-5","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"20 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was submitted to, and approved by, the Swedish Ethical Review Authority (\n                      \n                      ), reference number 2019\u201302570. The requirement for patient consent was waived by Swedish Ethical Review Authority according to the Act (2003:460) on ethical review of research involving humans. The study was in compliance with the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"OR has received personal compensation for education and\/or research consultation from LINK Sweden, ZimmerBiomet, Johnson&Johnson and Hereaus. ME reports consultancy for Gr\u00fcnenthal Sweden AB and Key2Complince AB.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"170"}}